1-3 of 3
Markus Peck-Radosavljevic
Close
Sort by
Journal Articles

Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Nezam Afdhal, MD, Ajay Duggal, MD, Toshimitsu Ochiai, Tomoko Motomiya, Takeshi Kano, MSc, Tsutae Nagata, MD, Markus Peck-Radosavljevic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 291.
https://doi.org/10.1182/blood.V130.Suppl_1.291.291
Published: 2017
Journal Articles

Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis

Bernhard Angermayr, Manfred Cejna, Maria Schoder, Fritz Wrba, Peter Valent, Alfred Gangl, Markus Peck-Radosavljevic
Journal: Blood
Blood (2002) 99 (11): 4246–4247.
https://doi.org/10.1182/blood-2002-01-0282
Published: 2002
Journal Articles

Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production

Markus Peck-Radosavljevic, Martina Wichlas, Johannes Zacherl, Gabriele Stiegler, Petra Stohlawetz, Michael Fuchsjäger, Anna Kreil, Sylvia Metz-Schimmerl, Simon Panzer, Rudolf Steininger, Ferdinand Mühlbacher, Peter Ferenci, Johann Pidlich, Alfred Gangl
Journal: Blood
Blood (2000) 95 (3): 795–801.
https://doi.org/10.1182/blood.V95.3.795.003k25_795_801
Published: 2000